Prospective data derived almost exclusively from men indicate that several plasma and genetic markers of thrombosis exist and that affected individuals are at markedly increased risk of future myocardial infarction (MI). However, data describing novel markers for coronary thrombosis among women are scant. The investigators therefore propose to comprehensively evaluate a series of thrombotic, inflammatory, and genetic markers for MI among participants in the Women's Health Initiative Observational Study (WHI-OS), a prospective cohort study of over 90,000 ethnically representative post-menopausal American women aged 50-79 years. Employing a prospective nested case-control design, they will assay baseline plasma and buffy coat samples for nine markers of increased thrombotic potential (tissue-type plasminogen activator (tPA), plasminogen activator inhibitor type 1 (PAI-1), total plasma homocysteine, prothrombin fragment F1+2, D-dimer, APC-R, C-reactive protein, interleukin-6, and sICAM-1) to determine whether elevations of these parameters lead to future MI or coronary death. They will also explore common genetic polymorphisms in the tPA, PAI-1, MTHFR, thrombomodulin, prothrombin, and factor V genes so that both inherited and environmental determinants of coronary thrombosis in women can simultaneously be evaluated. Case subjects will be WHI-OS participants who were free of cardiovascular disease at study entry and subsequently developed a documented MI or coronary death during follow-up (N = 650). Control subjects will be selected from study participants who remained free of disease during follow-up; controls will be 1:1 matched to cases by age, smoking status, ethnicity, and follow-up time. Data on usual risk factors, hormone replacement therapy, and standard lipid profiles will be used to evaluate for potential confounding and effect modification. The investigators note that the analyses will take advantage of a unique and unprecedented blood bank from a well-characterized, ethnically diverse, large-scale cohort of post-menopausal women with ongoing follow-up and high quality endpoint verification, thereby providing an efficient way to critically evaluate the hypothesized roles of hemostasis thrombosis and inflammation as risk factors for future MI and coronary death among American women.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL063293-04
Application #
6527201
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Wassef, Momtaz K
Project Start
1999-09-01
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2004-08-31
Support Year
4
Fiscal Year
2002
Total Cost
$481,007
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Mouton, Charles P; Rodabough, Rebecca J; Rovi, Susan L D et al. (2010) Psychosocial effects of physical and verbal abuse in postmenopausal women. Ann Fam Med 8:206-13
Wang, Xingyu; Cheng, Suzanne; Brophy, Victoria H et al. (2009) A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 40:683-95
Zee, Robert Y L; Michaud, Sherri E; Germer, Soren et al. (2009) Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach. Clin Chim Acta 403:139-41
Albert, Michelle A; Glynn, Robert J; Buring, Julie E et al. (2008) Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study. Atherosclerosis 197:297-302
Zee, Robert Y L; Hennessey, Hooman; Michaud, Sherri E et al. (2008) Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: a nested case-control approach. Atherosclerosis 201:124-9
Zee, Robert Y L; Michaud, Sherri E; Diehl, Kirsti A et al. (2008) Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism. Atherosclerosis 197:694-9
Malarstig, Anders; Eriksson, Per; Rose, Lynda et al. (2008) Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism. Clin Chem 54:833-40
Zee, Robert Y L; Ridker, Paul M (2007) Two common gene variants on chromosome 9 and risk of atherothrombosis. Stroke 38:e111
Hegener, H H; Diehl, K A; Kurth, T et al. (2006) Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach. J Thromb Haemost 4:1718-22
Zee, Robert Y L; Diehl, Kirsti A; Ridker, Paul M (2006) Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study. Atherosclerosis 187:332-5

Showing the most recent 10 out of 57 publications